Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Sabra Health Care REIT's 3-Year RORE % for the quarter that ended in Mar. 2026 was -19.72%.
The industry rank for Sabra Health Care REIT's 3-Year RORE % or its related term are showing as below:
SBRA's 3-Year RORE % is ranked worse than 62.69% of 839
companies
in the REITs industry
Industry Median: -0.22
vs SBRA: -19.72
Sabra Health Care REIT (NAS:SBRA) 3-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Sabra Health Care REIT 3-Year RORE % Related Terms
Sabra Health Care REIT 3-Year RORE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the REIT - Healthcare Facilities subindustry, Sabra Health Care REIT's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sabra Health Care REIT 3-Year RORE % vs REITs Industry
For the REITs industry and Real Estate sector, Sabra Health Care REIT's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where Sabra Health Care REIT's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.
Sabra Health Care REIT (SBRA) has a 3-Year RORE % of -19.72 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Sabra Health Care REIT and its competitors. According to the industry distribution chart, Sabra Health Care REIT ranks #526 out of 839 companies in the REITs industry, placing it in the top 62.7%.
Is Sabra Health Care REIT's 3-Year RORE % too high?
Sabra Health Care REIT's current 3-Year RORE % is -19.72. Based on the distribution chart, Sabra Health Care REIT ranks #526 out of 839 companies in the REITs industry, which is below the industry midpoint. Overall, Sabra Health Care REIT has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sabra Health Care REIT's 3-Year RORE % compare to NHI and HR?
According to the REITs industry distribution chart, Sabra Health Care REIT ranks #526 out of 839 companies for 3-Year RORE %. This places Sabra Health Care REIT in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a REITs company?
A good 3-Year RORE % depends on the REITs industry context. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Sabra Health Care REIT and its competitors. Sabra Health Care REIT's current 3-Year RORE % is -19.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sabra Health Care REIT stock overvalued right now?
Based on GuruFocus' analysis, Sabra Health Care REIT (SBRA) is currently considered Fairly Valued. The stock's GF Value™ is $19.45, compared to a current price of $19.88 — trading 2.2% above its estimated fair value. The current 3-Year RORE % is -19.72. Sabra Health Care REIT's overall GF Score™ is 79/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Sabra Health Care REIT (SBRA), the current 3-Year RORE % is -19.72 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sabra Health Care REIT (SBRA) Overvalued in 2026?
Based on GuruFocus' analysis, Sabra Health Care REIT stock appears to be overvalued.
The current stock price of $19.88 is trading 2.2% above its estimated GF Value™ of $19.45.
GuruFocus considers Sabra Health Care REIT to be Fairly Valued.
Key valuation signals for SBRA:
3-Year RORE %: -19.72
GF Value™: $19.45 vs. price of $19.88 (2.2% above fair value)
No single metric tells the full story. See the SBRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sabra Health Care REIT Inc is a healthcare facility real estate investment trust. The company operates one segment that owns and invests in healthcare real estate. All of the company's revenue is generated in the United States. Sabra's operations consist of nursing facilities, assisted living centers, and mental health facilities.
79GF Score
Get the complete analysis for SBRA
3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SBRA has been successfully added to your 
